Skip to main content
Journal of Medical Microbiology logoLink to Journal of Medical Microbiology
. 2025 May 23;74(5):002019. doi: 10.1099/jmm.0.002019

Species-level quantification of Faecalibacterium spp. in faeces of healthy Japanese adults

Masahiro Hirasaki 1, Ren Kadowaki 2, Adeline Ang 1, Gaku Harata 2, Kenji Miyazawa 2, Shintaro Maeno 3, Miguel Gueimonde 4, Akihito Endo 1,*
PMCID: PMC12102495  PMID: 40408134

Abstract

A corrigendum of this article has been published full details can be found at https://doi.org/10.1099/jmm.0.002043

Faecalibacterium prausnitzii has been considered one of the predominant microbes in the gut microbiota of healthy human adults. Moreover, due to its beneficial metabolites and its reduced population in patients with various disorders, this organism has been regarded as one of the key gut microbes in human health. However, following recent revisions in the taxonomy of the genus Faecalibacterium and F. prausnitzii, the reported population distribution and health benefits of this species have become unclear. In the present study, the population of nine species-level taxonomic groups (hereafter referred to as species) within Faecalibacterium was quantified at the species level in the faeces of healthy Japanese adults (n=88). qPCR, combined with rpoA-based species-specific primers, showed that Faecalibacterium taiwanense had the highest detection rate (prevalence) and copy number among Faecalibacterium spp., followed by Faecalibacterium longum, Faecalibacterium duncaniae and F. prausnitzii, while the remaining five species were detected only occasionally. The population of F. duncaniae varied significantly between age groups, being higher in individuals in their 40s and 50s compared to those in their 20s (P=0.047 and 0.002, respectively). The present study indicates that F. prausnitzii is not the predominant Faecalibacterium species in the healthy Japanese adults included in the present study. Future studies will shed light on the health benefits of the dominant Faecalibacterium spp.

Keywords: Faecalibacterium, gut microbiota, healthy human adult, quantification, rpoA-based qPCR

Introduction

Faecalibacterium prausnitzii has been considered one of the predominant microbes in the gut of healthy human adults [1]. It produces butyrate as its primary end product from carbohydrate metabolism, which exhibits multiple beneficial properties, including anti-inflammatory effects, maintenance of gut barrier function and regulation of gut immune homeostasis, contributing to host health through several pathways [2,3]. A reduced population of this microbe has been reported in the gut of patients with various disorders, including Crohn’s disease, ulcerative colitis, type 2 diabetes, mild cognitive impairment and allergic asthma [4,8]. Consequently, this organism has been regarded as a promising biomarker for healthy gut microbiota and a potential next-generation probiotic [1,9]. However, the taxonomical classification of this species, and of the genus Faecalibacterium in general, has been recently changed, and the importance of this specific microbe in host health remains unclear.

The genus Faecalibacterium was described in 2002 with a single species, F. prausnitzii [10], and for nearly two decades, the genus consisted solely of this species. However, several studies suggested genomic heterogeneity of F. prausnitzii during this period [11,14]. In 2023, Tanno et al. proposed nine species-level taxonomic groups (hereafter referred to as species) within Faecalibacterium spp. (including F. prausnitzii) found in the human gut, based on genome-based similarity analysis [14,15]. Five of the nine groups were recently (re)classified as Faecalibacterium butyricigenerans, Faecalibacterium duncaniae, Faecalibacterium hattorii, Faecalibacterium longum and Faecalibacterium taiwanense [16,18]. This (re)classification/division of F. prausnitzii has led to debate regarding its predominant population and its reported importance in human health.

To address these concerns, rpoA-based uantitative PCR (qPCR) was recently developed to quantify Faecalibacterium spp. at the species level [15]. A previous study using this method quantified Faecalibacterium spp. in a small number of healthy adults (n=6) and reported that F. prausnitzii was quantified in only a limited number of subjects. Instead, F. taiwanense (described as Group 3 in the study), F. longum and F. butyricigenerans were more commonly detected in the tested subjects. These findings suggest that these three species are more abundant in healthy adults than F. prausnitzii and may be associated with host health. However, the study was preliminary and involved a limited number of subjects.

In the present study, to confirm the population distribution of Faecalibacterium spp. at the species level in healthy individuals, faecal samples obtained from 88 healthy Japanese adults were analysed using rpoA-based qPCR. The population of Faecalibacterium spp. was statistically examined in relation to the basic background information of the subjects.

Methods

Subjects and samples

The study was approved by the Ethics Committee of the Shinkohkai Med. Corp., Japan, and conducted in accordance with the Declaration of Helsinki. All subjects were fully informed about the purpose of the study, and a detailed procedure was provided. Written informed consent was obtained from all participants. This study was registered in the UMIN Clinical Trial Registry as UMIN000025888.

In total, 96 healthy Japanese adult volunteers (22 males and 74 females, aged 20–59 years) were initially recruited between January and February 2017. However, eight volunteers were excluded from the present study due to limitations in sample availability. Faecal samples were collected immediately after defecation into plastic containers, transported to the Technical Research Laboratory, Takanashi Milk Products Co., Ltd., at −20 °C, and stored at −80 °C until analysis. These 88 volunteers were not visiting a hospital and were free from subjective symptoms of diseases and severe pollinosis [19]. The basic physiological characteristics of the subjects are presented in Table 1. Stool consistency in the present study ranged from type 2 to type 6 based on the Bristol Stool Form Scale; types 1 and 7 were not included. A previous study reported that stool water content does not vary markedly among different consistencies (e.g. hard and formed, soft but formed and loose and unformed) [20].

Table 1. Physiological characteristics of the subjects (n=88).

Sex Male 22 (25 %)
Female 66 (75 %)
Age 20 s (20<X<29) 17
median (Q1-Q3) 30 s (30<X<39) 20
=41.5(32.75–50) 40 s (40<X<49) 27
50 s (50<X<59) 24
BMI <20 39
median (Q1-Q3) 20<X 25 40
=20.4(18.21–22.57) 25<X<30 7
>30 2

DNA extraction

DNA was extracted from faecal samples using the NucleoSpin® DNA Stool kit (MACHEREY-NAGEL GmbH and Co., KG, Düren, Germany) following the manufacturer’s instructions within 1 month of sample receipt. The DNA concentration and quality were assessed using a Qubit 3.0 fluorometer (Invitrogen, Waltham, MA, USA).

16S rRNA gene sequencing

The sequencing library was prepared using index-appended amplicons of the V3–V4 region of the 16S rRNA gene according to the 16S Metagenomic Sequencing Library Preparation manual (Illumina, San Diego, CA, USA). Pair-end sequencing was performed on the MiSeq platform (Illumina) using a MiSeq Reagent Kit v3 (600 cycles) (Illumina). Data analysis was conducted using QIIME2 (v.2024.5) with default settings. A total of 9,885,007 sequence reads were obtained (average±sd per samples=56,164±23,803), which were imported into QIIME2. Quality assessment, filtering, barcode trimming and chimaera detection were performed using the DADA2 pipeline (v1.30.0), resulting in a total of 6,777,082 high-quality reads. Taxonomic classification was assigned to amplicon sequence variants using the SILVA database (release 138) with taxonomic classification at >99% confidence. Sequencing data were deposited in the DDBJ Sequence Read Archive under the accession numbers DRR657747–DRR657922.

Quantification of Faecalibacterium spp.

Quantification of Faecalibacterium spp. was performed as described previously [15]. FastStart Essential DNA Green Master Mix combined with the LightCycler 96 system (Roche, Basel, Switzerland) was used for qPCR according to the manufacturer’s instructions. All primers used in this qPCR study are listed in Table S1, available in the online Supplementary Material. The nine species within Faecalibacterium, whose classification is summarized in Table 2, were quantified using nine primer pairs specific to the rpoA gene of each species [15]. The rpoA gene is among the housekeeping genes of bacteria, and all Faecalibacterium genomes contain a single copy of the rpoA gene [15]. The qPCR programme consisted of an initial denaturation at 95 °C for 10 min and 45 cycles of 95 °C for 10 s, 60 °C for 10 s and 72 °C for 15–25 s (Table S1). Standard curves were generated for each primer pair using synthetic rpoA gene DNA of the targeted species, described in a previous study [15]. In this study, F. gallinarum was not included due to its distinct origin (i.e. chicken) [16]. Additionally, Faecalibacterium wellingii, which was only recently validated (validated in January 2025) [21], was not included in the present study.

Table 2. Prevalence (%) and population [median and IQR (Q1–Q3) of log10 copies g−1 of faeces] of Faecalibacterium genus and each Faecalibacterium spp. in healthy Japanese subjects (n=88).

Prevalence (%) Median (Q1–Q3) Correlation coefficient*
Genus 97.7 7.81 (7.30–8.35) 0.507
F. prausnitzii (Group 1) 72.7 4.92 (BQL–6.13) 0.522
Group 2 6.8 BQL (BQL–BQL) 0.147
F. taiwanense (Group 3) 89.8 5.85 (4.77–6.70) 0.583
F. longum (Group 4) 77.3 5.48 (4.02–6.30) 0.375
Group 5 34.1 BQL (BQL–4.37) 0.109
F. duncaniae (Group 6) 72.7 5.61 (BQL–6.58) 0.475
F. hattorii (Group 7) 9.1 BQL (BQL–BQL) 0.247
Group 8 34.0 BQL (BQL–4.47) 0.126
F. butyricigenerans (Group 9) 20.5 BQL (BQL–BQL) −0.061

*Correlation coefficients between the relative abundance of the genus Faecalibacterium, as determined by 16S rRNA gene sequencing, and the population of the genus Faecalibacterium and each species, as determined by qPCR, are presented.

BQL, below quantification limit (3.43).

Genus-level quantification of Faecalibacterium was performed using the primer pair Fprau223F/Fpau420R, specific to the 16S rRNA gene of all Faecalibacterium spp., designed by Bartosh and coworkers [22]. The qPCR programme for genus-level quantification consisted of an initial denaturation at 95 °C for 10 min, followed by 45 cycles of 95 °C for 10 s, 58 °C for 10 s and 72 °C for 20 s. A standard curve was generated by using serially diluted synthetic 16S rRNA gene DNA of F. prausnitzii ATCC 27768T, as described previously [14].

In all qPCR assays, a melting peak analysis was conducted to confirm specific amplification. When melting temperatures of amplicons differed >1.5 °C from that of the reference DNA, the amplification was considered negative. Samples were run in duplicate on the same plate, and the mean and sd were obtained. The quantification limit of qPCR was determined based on serially diluted synthetic DNA. If amplification was not observed or observed but below the quantification limit (BQL), the result was recorded as BQL.

Statistical analysis

The Mann–Whitney U test was used to compare Faecalibacterium spp. populations between two groups, while the Kruskal–Wallis test with Bonferroni correction was applied when comparing three or more groups. A P value of <0.05 was considered statistically significant. Statistical analysis was performed using IBM SPSS Statistics for Windows (version 26). The correlation coefficients between relative abundance of Faecalibacterium based on 16S rRNA gene sequencing and population of the genus Faecalibacterium and each species as determined by qPCR were determined using Spearman’s rank correlation in R (ver. 4.4.2).

Results

Microbial composition of faecal samples determined by 16S rRNA gene sequencing

The microbial composition in faecal samples was initially analysed by 16S rRNA gene sequencing to determine the relative abundance of Faecalibacterium at the genus level. Among the healthy Japanese subjects tested, the genus Bacteroides exhibited the highest relative abundance (median=22.98%), followed by Blautia (median=6.28%) (Fig. 1). Faecalibacterium ranked third, with a median (interquartile range, IQR, Q1–Q3) of 5.49% (1.97–8.64%).

Fig. 1. Relative abundance of the top eight genera (median>1%) in healthy Japanese subjects (n=88) based on 16S rRNA gene sequencing. The box plots represent the median and IQR, and the dots indicate individuals.

Fig. 1.

Quantification and prevalence of Faecalibacterium spp.

Detection and quantification of the Faecalibacterium genus were performed using 16S-based qPCR, while species-level quantification was conducted using rpoA-based qPCR. Melting peak analysis was performed to confirm the reliability of the amplification. The prevalence of the genus Faecalibacterium and individual species is summarized in Table 2. Faecalibacterium genus was detected in 97.7% of the subjects. At the species level, F. taiwanense (Group 3) was detected in 89.8% of the subjects, and F. longum (Group 4), F. duncaniae (Group 6) and F. prausnitzii (Group 1) were seen in 70–80% of the subjects. Groups 5 and 8, as well as F. butyricigenerans (Group 9), were detected in 34.1, 34.0 and 20.5% of the samples, respectively. F. hattorii (Group 7) and Group 2 were detected in fewer than 10% of subjects. Non-specific amplification was observed for qPCR of the latter five species with low prevalence, which were considered negative in prevalence analysis.

The median (IQR, Q1–Q3) of Faecalibacterium genus-level population (log10 copies g−1 faeces) in the 88 samples was 7.81 (7.30–8.35) (Fig. 2 and Table 2). Among species, the highest median (Q1–Q3) was recorded for F. taiwanense (Group 3) at 5.85 (4.77–6.70), followed by F. duncaniae (Group 6) at 5.61 (BQL–6.58), F. longum (Group 4) at 5.48 (4.02–6.30) and F. prausnitzii (Group 1) at 4.92 (BQL–6.12) (Fig. 2 and Table 2). The medians of F. hattorii (Group 7), F. butyricigenerans (Group 9) and Groups 2, 5 and 8 were BQL.

Fig. 2. Population (log10 copies g−1 of faeces) of Faecalibacterium genus and each Faecalibacterium species in healthy Japanese subjects (n=88) as determined by qPCR. The box plots represent the median and IQR, and the dots indicate individuals. Quantification limit (3.43) was indicated with the dashed line. Different letters (a–e) on top of the bars indicate significant differences (P<0.05) by the Kruskal–Wallis test with multiple comparisons by the Bonferroni correction.

Fig. 2.

Correlation analysis was conducted between the relative abundance of the Faecalibacterium genus, as determined by 16S rRNA gene sequencing, and the population of the genus and each species, as determined by qPCR. The results indicate that the population of the genus, F. taiwanense (Group 3) and F. prausnitzii (Group 1) showed correlation with the relative abundance of the Faecalibacterium genus (correlation coefficient >0.5, P<0.001) (Table 2). Populations of F. duncaniae (Group 6) and F. longum (Group 4) showed a weak correlation (correlation coefficient >0.3, P<0.001), while the other species showed no significant correlations.

Population of Faecalibacterium spp. across different physiological backgrounds in healthy Japanese subjects

Subjects were grouped based on physiological characteristics, including sex, age and body mass index (BMI), and populations of Faecalibacterium spp. were compared among groups. Among different age groups, F. duncaniae (Group 6) showed a significant difference in population size (P=0.004) (Table 3). The levels of F. dancaniae (Group 6) were significantly higher in subjects in their 40s (median, Q1–Q3=5.96, 3.60–6.65; P=0.047) and 50s (6.29, 4.69–6.84; P=0.002) compared to those in their 20s (BQL, BQL–3.52) (Fig. 3). Similarly, the levels of the Faecalibacterium genus, F. prausnitzii (Group 1), F. taiwanense (Group 3) and F. longum (Group 4), exhibited trends towards differences among age groups (P<0.1, Table 3), also increasing with age but not reaching statistical significance. No statistically significant differences were found in the population of Faecalibacterium spp. between sexes or BMI groups.

Table 3. Population [median and IQR (Q1–Q3) of log10 copies g−1 of faeces] of Faecalibacterium genus and each Faecalibacterium spp. in different age groups.

Age Median (Q1–Q3) Adjusted P value
Genus 20s 7.47 (6.61–7.68)
30s 7.91 (7.59–8.35) 0.056
40s 8.89 (7.15–8.56)
50s 8.09 (7.50–8.35)
F. prausnitzii (Group 1) 20s 4.27 (BQL–5.12)
30s 4.69 (BQL–5.91) 0.097
40s 4.97 (3.83–6.18)
50s 5.48 (3.97–6.36)
F. taiwanense (Group 3) 20s 5.21 (4.51–6.30)
30s 5.76 (4.81–6.50) 0.055
40s 5.59 (4.06–6.55)
50s 6.37 (5.79–7.18)
F. longum (Group 4) 20s 5.33 (4.32–5.70)
30s 5.62 (4.47–6.34) 0.054
40s 4.83 (3.50–6.09)
50s 6.07 (5.42–6.50)
F. duncaniae (Group 6) 20s BQL (BQL–3.53)
30s 4.08 (BQL–6.37) 0.004
40s 5.96 (3.55–6.65)
50s 6.29 (4.69–6.85)

Populations of Faecalibacterium spp. among different age groups were statistically analysed with the Kruskal–Wallis test with multiple comparisons by the Bonferroni correction.

BQL, below quantification limit (3.43).

Fig. 3. Levels of F. duncaniae (Group 6) among different age groups. The box plots represent the median and IQR, and the separated dots indicate outliers. The quantification limit (3.43) was indicated with a dashed line. The Kruskal–Wallis test with multiple comparisons by the Bonferroni correction was used for statistical analysis. *, adjusted P value<0.05; **, adjusted P value<0.01.

Fig. 3.

Discussion

Due to recent significant taxonomic changes of the genus Faecalibacterium and F. prausnitzii, the reported population and specific roles of this species have become unclear. The present study characterized the population of Faecalibacterium at the species level in healthy Japanese subjects. The genus Faecalibacterium was the third most abundant genus, with a median relative abundance of 5.49%, a level similar to those previously reported in the adult gut [23,24]. qPCR using rpoA-based species-specific primers revealed that F. taiwanense was the most prevalent and the numerically dominant Faecalibacterium species among the subjects, followed by F. longum, F. duncaniae and F. prausnitzii. This is the first study to demonstrate that F. taiwanense, F. longum and F. duncaniae, rather than F. prausnitzii, are the predominant Faecalibacterium species in the human gut. A previous study using a small number of subjects (n=6) suggested this possibility [15], and F. longum and F. duncaniae showed similar population sizes with F. taiwanense but were found at slightly lower prevalence rates. However, it should be noted that the subject groups in both the present and previous studies were not fully representative of the general healthy Japanese adult population due to factors such as gender imbalance. Further studies would help to understand the predominance and significance of Faecalibacterium spp. in the population.

A previous study suggested F. butyricigenerans as one of the most prevalent Faecalibacterium species among six subjects [15], but its prevalence was low in the present study. This discrepancy may be due to non-specific amplification in qPCR of the species found in the present study, suggesting that F. butyricigenerans is a minor species in healthy Japanese adults. Indeed, De Filippis et al. described 12 Faecalibacterium clades (A–L) from the human gut using 2,859 globally collected Faecalibacterium genomes, but no clade corresponding to F. butyricigenerans was seen [23]. The number of copies per g of faeces found at the species level showed slight discrepancies compared to those at the genus level (Fig. 2 and Table 2). This difference can be attributed to the variation in copy numbers between the 16S rRNA gene, used for genus-level quantification, and the rpoA gene, used for species-level quantification, as described previously [15]. In the Faecalibacterium genome, the 16S rRNA gene is present in six copies, while the rpoA gene is present in a single copy [14,15]. Therefore, the copy number detected at the genus level using the 16S rRNA gene is theoretically six times higher than the sum of the copy numbers detected at the species level using the rpoA gene.

Statistical analysis based on physiological background showed significant differences only in F. duncaniae across age groups, with higher populations in subjects in their 40s and 50s compared to those in their 20s. The reason for this age-related difference remains unclear, though diet habits may play a role. Further studies are needed to investigate the colonization and development of Faecalibacterium species with ageing.

Previous studies have reported F. prausnitzii as the dominant gut microbe in healthy human adults and have linked its reduced population in patients with several disorders [7,25]. However, our findings disagreed with its predominant position. F. taiwanense, F. longum and F. duncaniae exhibited higher populations than F. prausnitzii. The type strain of F. duncaniae, strain A2-165T, is the most well-characterized strain among Faecalibacterium spp., and its potential health benefits have been reported in previous in vitro and in vivo studies [26,27]. The importance of F. taiwanense and F. longum remains poorly understood. Future studies should elucidate the health benefits of these dominant Faecalibacterium spp. through in vitro, in vivo and clinical studies.

Supplementary material

Uncited Table S1.
jmm-74-02019-s001.pdf (108.6KB, pdf)
DOI: 10.1099/jmm.0.002019

Acknowledgement

The authors wish to thank the volunteers participating in the study.

Abbreviations

BMI

body mass index

BQL

below the quantification limit

IQR

interquartile range

Footnotes

Funding: This work was supported by the JSPS KAKENHI Grant No. 24K08691 and by Takanashi Milk Products Co., Ltd.

Author contributions: Conceptualization: G.H., K.M. and A.E. Data curation: M.H., R.K., G.H., S.M. and A.E. Formal analysis: M.H., R.K., S.M. and A.E. Funding acquisition: G.H., K.M. and A.E. Investigation: M.H., R.K., A.A.L.X., G.H., K.M. and A.E. Methodology: G.H., K.M. and A.E. Project administration: G.H., K.M. and A.E. Resources: G.H., K.M. and A.E. Supervision: A.E. Validation: S.M., M.G. and A.E. Visualization: M.H., S.M. and A.E. Writing – original draft: A.E. Writing – review and editing: G.H., K.M., S.M., M.G. and A.E.

Ethical statement: The study was approved by the Ethics Committee of the Shinkohkai Med. Corp., Japan. All subjects were fully informed regarding the purpose, and a detailed procedure of the study was provided. A written informed consent was obtained from all participants.

Consent to participate: A written informed consent was obtained from all participants.

Contributor Information

Masahiro Hirasaki, Email: h.masahiro01@gmail.com.

Ren Kadowaki, Email: r-kadowaki@takanashi-milk.co.jp.

Adeline Ang, Email: 10724002@nodai.ac.jp.

Gaku Harata, Email: g-harata@takanashi-milk.co.jp.

Kenji Miyazawa, Email: ke-miyazawa@takanashi-milk.co.jp.

Shintaro Maeno, Email: maeno.s@yamaguchi-u.ac.jp.

Akihito Endo, Email: a3endou@nodai.ac.jp.

References

  • 1.Lopez-Siles M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J. 2017;11:841–852. doi: 10.1038/ismej.2016.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kinoshita M, Suzuki Y, Saito Y. Butyrate reduces colonic paracellular permeability by enhancing PPARgamma activation. Biochem Biophys Res Commun. 2002;293:827–831. doi: 10.1016/S0006-291X(02)00294-2. [DOI] [PubMed] [Google Scholar]
  • 3.Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504:446–450. doi: 10.1038/nature12721. [DOI] [PubMed] [Google Scholar]
  • 4.Zhang X, Shen D, Fang Z, Jie Z, Qiu X, et al. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One. 2013;8:e71108. doi: 10.1371/journal.pone.0071108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ueda A, Shinkai S, Shiroma H, Taniguchi Y, Tsuchida S, et al. Identification of Faecalibacterium prausnitzii strains for gut microbiome-based intervention in Alzheimer’s-type dementia. Cell Rep Med . 2021;2:100398. doi: 10.1016/j.xcrm.2021.100398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Demirci M, Tokman HB, Uysal HK, Demiryas S, Karakullukcu A, et al. Reduced Akkermansia muciniphila and Faecalibacterium prausnitzii levels in the gut microbiota of children with allergic asthma. Allergol Immunopathol. 2019;47:365–371. doi: 10.1016/j.aller.2018.12.009. [DOI] [PubMed] [Google Scholar]
  • 7.Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA. 2008;105:16731–16736. doi: 10.1073/pnas.0804812105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15:1183–1189. doi: 10.1002/ibd.20903. [DOI] [PubMed] [Google Scholar]
  • 9.Langella P, Guarner F, Martín R. Editorial: next-generation probiotics: from commensal bacteria to novel drugs and food supplements. Front Microbiol. 2019;10:1973. doi: 10.3389/fmicb.2019.01973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Duncan SH, Hold GL, Harmsen HJM, Stewart CS, Flint HJ. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol . 2002;52:2141–2146. doi: 10.1099/00207713-52-6-2141. [DOI] [PubMed] [Google Scholar]
  • 11.Lopez-Siles M, Khan TM, Duncan SH, Harmsen HJM, Garcia-Gil LJ, et al. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Appl Environ Microbiol. 2012;78:420–428. doi: 10.1128/AEM.06858-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Benevides L, Burman S, Martin R, Robert V, Thomas M, et al. New insights into the diversity of the genus Faecalibacterium. Front Microbiol. 2017;8:1790. doi: 10.3389/fmicb.2017.01790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Fitzgerald CB, Shkoporov AN, Sutton TDS, Chaplin AV, Velayudhan V, et al. Comparative analysis of Faecalibacterium prausnitzii genomes shows a high level of genome plasticity and warrants separation into new species-level taxa. BMC Genom. 2018;19:931. doi: 10.1186/s12864-018-5313-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Tanno H, Maeno S, Salminen S, Gueimonde M, Endo A. 16S rRNA gene sequence diversity in Faecalibacterium prausnitzii-complex taxa has marked impacts on quantitative analysis. FEMS Microbiol Ecol. 2022;98:fiac004. doi: 10.1093/femsec/fiac004. [DOI] [PubMed] [Google Scholar]
  • 15.Tanno H, Chatel J-M, Martin R, Mariat D, Sakamoto M, et al. New gene markers for classification and quantification of Faecalibacterium spp. in the human gut. FEMS Microbiol Ecol. 2023;99:fiad035. doi: 10.1093/femsec/fiad035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sakamoto M, Sakurai N, Tanno H, Iino T, Ohkuma M, et al. Genome-based, phenotypic and chemotaxonomic classification of Faecalibacterium strains: proposal of three novel species Faecalibacterium duncaniae sp. nov., Faecalibacterium hattorii sp. nov. and Faecalibacterium gallinarum sp. nov. Int J Syst Evol Microbiol. 2022;72 doi: 10.1099/ijsem.0.005379. [DOI] [PubMed] [Google Scholar]
  • 17.Zou Y, Lin X, Xue W, Tuo L, Chen M-S, et al. Characterization and description of Faecalibacterium butyricigenerans sp. nov. and F. longum sp. nov., isolated from human faeces. Sci Rep. 2021;11:11340. doi: 10.1038/s41598-021-90786-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Liou J-S, Zhang W-L, Hsu L-W, Chen C-C, Wang Y-T, et al. Faecalibacterium taiwanense sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2024;74:006413. doi: 10.1099/ijsem.0.006413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Miyazawa K, Harata G, Yoda K, Yamazaki K, He F, et al. Effects of intake of Lactobacillus rhamnosus GG on intestinal environment and skin condition in healthy adults: a rondomized, double-blind, placebo-controlled study. Int J Probiotics Prebiotics. 2018;13:11–18. [Google Scholar]
  • 20.Bliss DZ, Savik K, Jung H, Jensen L, LeMoine M, et al. Comparison of subjective classification of stool consistency and stool water content. J Wound Ostomy Continence Nurs. 1999;26:137–141. doi: 10.1016/s1071-5754(99)90031-1. [DOI] [PubMed] [Google Scholar]
  • 21.Oren A, Göker M. Validation List no. 221: valid publication of new names and new combinations effectively published outside the IJSEM. Int J Syst Evol Microbiol. 2025;75 doi: 10.1099/ijsem.0.006562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bartosch S, Fite A, Macfarlane GT, McMurdo MET. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol. 2004;70:3575–3581. doi: 10.1128/AEM.70.6.3575-3581.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.De Filippis F, Pasolli E, Ercolini D. Newly explored Faecalibacterium diversity is connected to age, lifestyle, geography, and disease. Curr Biol. 2020;30:4932–4943. doi: 10.1016/j.cub.2020.09.063. [DOI] [PubMed] [Google Scholar]
  • 24.Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, et al. Enterotypes of the human gut microbiome. Nature . 2011;473:174–180. doi: 10.1038/nature09944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Varela E, Manichanh C, Gallart M, Torrejón A, Borruel N, et al. Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis. Aliment Pharmacol Ther. 2013;38:151–161. doi: 10.1111/apt.12365. [DOI] [PubMed] [Google Scholar]
  • 26.Quévrain E, Maubert MA, Michon C, Chain F, Marquant R, et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease. Gut. 2016;65:415–425. doi: 10.1136/gutjnl-2014-307649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Chollet L, Heumel S, Deruyter L, Bouilloux F, Delval L, et al. Faecalibacterium duncaniae as a novel next generation probiotic against influenza. Front Immunol. 2024;15:1347676. doi: 10.3389/fimmu.2024.1347676. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Uncited Table S1.
jmm-74-02019-s001.pdf (108.6KB, pdf)
DOI: 10.1099/jmm.0.002019

Articles from Journal of Medical Microbiology are provided here courtesy of Microbiology Society

RESOURCES